Korro Bio, Inc. Operating Income Loss

• Korro Bio, Inc. showed a decrease of -32.6% in Operating Income Loss from 2024 to 2025.
• This data is from Korro Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Korro Bio, Inc.'s Operating Income Loss has declined by 647.3%.
• Historical annual values: Fiscal year 2025: -$121.86 million | Fiscal year 2024: -$91.91 million | Fiscal year 2023: -$84.53 million | Fiscal year 2022: -$59.00 million | Fiscal year 2021: -$84.03 million | Fiscal year 2020: -$27.55 million | Fiscal year 2019: -$20.68 million | Fiscal year 2018: -$18.94 million | Fiscal year 2017: -$16.31 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026